VEGFB and hypertensive disorder: In this study, the author revealed that VEGF-B participates in the progression of obesity-associated hypertension in two mouse models of obesity, and they described that inhibition of VEGF-B may have benefit for the treatment of obesity-associated hypertension (Zhu et al., 2020[44]).